Clinical Trial Update: Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

View source ↗

Summary

The clinical trial update reports completion of a study evaluating high-sensitivity C-reactive protein as a clinical marker of inflammatory atherogenic dyslipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Dyslipidemia | Status: COMPLETED